Peers for comparison


Market capitalization
‪187.95 B‬ USDLarge cap
2.72 USD
‪6.50 B‬ USD
‪44.33 B‬ USD
‪1.72 B‬
Beta (1Y)
−0.48
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
‪115 K‬
Change (1Y)
‪+1 K‬+0.88%
Revenue / Employee (1Y)
‪385.46 K‬ USD
Net income / Employee (1Y)
‪56.52 K‬ USD

Company info


CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
IPO date
Mar 1, 1937
ISIN
US0028241000
CUSIP
002824100
FIGI
BBG000B9ZXB4
Identifiers
ISIN US0028241000
CFI code
ESVUFR
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateApr 15, 2043
Coupon4.75% (Fixed)
Maturity dateMar 15, 2066
Coupon5.60% (Fixed)
Maturity dateMar 15, 2056
Coupon5.50% (Fixed)
Maturity dateNov 30, 2046
Coupon4.90% (Fixed)
Maturity dateApr 15, 2043
Coupon4.75% (Fixed)
Maturity dateMay 27, 2040
Coupon5.30% (Fixed)
Maturity dateMar 15, 2038
Coupon4.75% (Fixed)
Maturity dateApr 1, 2039
Coupon6.00% (Fixed)
Maturity dateNov 30, 2037
Coupon6.15% (Fixed)
Maturity dateMar 15, 2036
Coupon4.65% (Fixed)

See all ABT bonds 

Weight0.23%
Market value‪5.43 B‬
Weight3.77%
Market value‪4.65 B‬
Weight0.26%
Market value‪4.49 B‬
Weight0.29%
Market value‪2.52 B‬
Weight0.28%
Market value‪2.29 B‬
Weight0.65%
Market value‪1.63 B‬
Weight2.73%
Market value‪1.38 B‬
Weight0.76%
Market value‪967.55 M‬
Weight17.32%
Market value‪704.76 M‬
Weight0.73%
Market value‪696.61 M‬
Weight0.28%
Market value‪526.23 M‬

Explore more ETFs 

Frequently asked questions


Abbott Laboratories is scheduled to release its next earnings report on Jan 27, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
ABT stock is 2.10% volatile and has beta coefficient of −0.48.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like ABT are typically less volatile than smaller companies

Track every detail on Abbott Laboratories stock chart and check out the list of the most volatile stocks — is Abbott Laboratories there?
To understand the ABT stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +1.18%
– 1 week — −2.30%
– 1 month — +4.29%

ABT all-time low was 0.11 USD (Oct 4, 1974), and its highest price is 142.60 USD (Dec 27, 2021). Find more dynamics in the Stock Heatmap and on the Abbott Laboratories stock chart.
Abbott Laboratories market capitalization is ‪187.95 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Abbott Laboratories stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Abbott Laboratories stacks up against other companies
The safest way to buy Abbott Laboratories stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade ABT directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 16, 2026, the company has ‪115 K‬ employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Abbott Laboratories pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.

Its recent dividend yield was around 1.92%, with a payout ratio of 64.54%, compared to 1.98% and 29.33% in the previous period.

What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance

Explore all this in Abbott Laboratories financials.
Investing in Abbott Laboratories depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Abbott Laboratories financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our ABT technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — neutral

Combine fundamental and technical analysis for better results.
Abbott Laboratories stock ticker depends on the exchange where it’s listed. On the NYSE, its primary exchange, Abbott Laboratories stocks trade under the symbol ABT.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
ABT earnings for the last quarter are 1.42 USD per share, whereas the estimation was 1.42 USD, resulting in a 0.03% surprise. The estimated earnings for the next quarter are 1.64 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in Abbott Laboratories financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Abbott Laboratories revenue for the last quarter amounts to ‪13.01 B‬ USD despite the estimated figure of ‪12.99 B‬ USD. In the next quarter revenue is expected to reach ‪13.21 B‬ USD.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in Abbott Laboratories financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
ABT net income for the last quarter is ‪920.00 M‬ USD, while the quarter before that showed ‪928.00 M‬ USD of net income which accounts for −0.86% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Abbott Laboratories financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
Abbott Laboratories does pay dividends, which are distributed quarterly. The most recent dividend per share was 0.63 USD, with a trailing twelve-month (TTM) dividend yield of 2.32%.

Explore more details on Abbott Laboratories dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
ABT reached its all-time high of 142.60 USD on Dec 27, 2021. Its all-time low was 0.11 USD and was reached on Oct 4, 1974.

Explore the Abbott Laboratories stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Abbott Laboratories EBITDA is ‪10.78 B‬ USD, with an EBITDA margin of 25.67%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Abbott Laboratories statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 100.00 USD and 130.00 USD for ABT, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance